The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
Rösch, T., Lightdale, C. J., Botet, J. F., Boyce, G. A., Sivak, M. V., Yasuda, K., Heyder, N., Palazzo, L., Dancygier, H., Schusdziarra, V., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262601 · Cited by 713
Magnani, J. L., Steplewski, Z., Koprowski, H., & Ginsburg, V. (1983) · PubMed · Cited by 589
KIM, J., LEE, K. T., LEE, J. K., PAIK, S. W., RHEE, J. C., & CHOI, K. W. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03219.x · Cited by 394
EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma
Mertz, H. R., Sechopoulos, P., Delbeke, D., & Leach, S. D. (2000) · Gastrointestinal Endoscopy · doi:10.1067/mge.2000.107727 · Cited by 321
Ni, X. G., Bai, X. F., Mao, Y. L., Shao, Y. F., Wu, J. X., Shan, Y., Wang, C. F., Wang, J., Tian, Y. T., Liu, Q., et al. (2005) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2004.09.007 · Cited by 303
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice
Mann, D., Edwards, R., Ho, S., Lau, W., & Glazer, G. (2000) · European Journal of Surgical Oncology (EJSO) · doi:10.1053/ejso.1999.0925 · Cited by 294
CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
Carpelan-Holmström, M. A., Louhimo, J. M., Stenman, U., Alfthan, H. V., & Haglund, C. (2002) · PubMed · Cited by 216
Kim, H. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00290-7 · Cited by 198
Diagnosis of Pancreatic Carcinoma
Niederau, C., & Grendell, J. H. (1992) · Pancreas · doi:10.1097/00006676-199201000-00011 · Cited by 156
Howard, T. J., Chin, A. C., Streib, E. W., Kopecky, K. K., & Wiebke, E. A. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00132-3 · Cited by 114
Nilsson, O., Johansson, C., Glimelius, B. L. G., Persson, B., Nørgaard‐Pedersen, B., Andrén‐Sandberg, Å., & Lindholm, L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.44 · Cited by 89
Ritts, R. E., Nagorney, D. M., Jacobsen, D. J., Talbot, R. W., & Zurawski, V. R. (1994) · Pancreas · doi:10.1097/00006676-199411000-00006 · Cited by 85
CA19-9 as a Screening and Diagnostic Tool in Symptomatic Patients
Satake, K., Takeuchi, T., Homma, T., et al. (1994) · Pancreas · doi:10.1097/00006676-199411000-00005 · Cited by 76
The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma.
Nazlı, O., Bozdağ, A. D., Tansuğ, T., Kir, R., & Kaymak, E. (2000) · PubMed · Cited by 72
Ozkan, H., Kaya, M., & Cengiz, A. (2003) · PubMed · Cited by 71
Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang, X., Tao, H., & Zou, S.-C. (2004) · PubMed · Cited by 68
Slesak, B., Harłoziñska-Szmyrka, A., Knast, W., Sedlaczek, P., van Dalen, A., & EINARSSON, R. (2000) · Cancer · Cited by 68
Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer
Ventrucci, M., Cipolla, A., Racchini, C., et al. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000037803.32013.aa · Cited by 64
Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer
Jiang, J. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i11.1675 · Cited by 60
Cerwenka, H., Aigner, R., Bacher, H., Werkgartner, G., El-Shabrawi, A., Quehenberger, F., & Mischinger, H. J. (1999) · PubMed · Cited by 55
The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.
Schulze, G. (2001) · PubMed · Cited by 53
Comparison of CA19-9 with Other Tumor Markers in the Diagnosis of Cancer of the Pancreas
Satake, K., & Takeuchi, T. (1994) · Pancreas · doi:10.1097/00006676-199411000-00008 · Cited by 50
Malesci, A., Montorsi, M., Mariani, A., Santambrogio, R., Bonato, C., Bissi, O., Tacconi, M., Wizemann, G., & Spina, G. (1992) · Pancreas · doi:10.1097/00006676-199207000-00012 · Cited by 42
Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
Nishida, K., Sugiura, M., Yoshikawa, T., & Kondo, M. (1985) · Gut · doi:10.1136/gut.26.5.450 · Cited by 21
Effectiveness of Multivariate Analysis of Tumor Markers in Diagnosis of Pancreatic Carcinoma
Kuno, N., Kurimoto, K., Fukushima, M., Hayakawa, T., Shibata, T., Suzuki, T., Sakakibara, A., Katada, N., Nakano, S., Takayama, T., et al. (1994) · Pancreas · doi:10.1097/00006676-199411000-00009 · Cited by 18
Palsson, B. Ø., Masson, P., & Andrén‐Sandberg, Å. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098296 · Cited by 11
Cited by
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00141-0 · Cited by 2,212
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
Ballehaninna, U. K., & Chamberlain, R. S. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2011.021 · Cited by 701
Metadata
- Authors
- Goonetilleke, K. S., & Siriwardena, A. K.
- Venue
- European Journal of Surgical Oncology (EJSO)
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 33
- Issue
- 3
- Pages
- 266-270
- ISSN
- 0748-7983 (ISSN-L)
- OpenAlex
- W2121289368
- Cited by
- 877
- References
- 26
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.